Fig. 2From: CD45RA+CCR7− CD8 T cells lacking co-stimulatory receptors demonstrate enhanced frequency in peripheral blood of NSCLC patients responding to nivolumabPatients responding to nivolumab show high numbers of CD8 T cells. Graphs show numbers of αβ and γδ T cells in peripheral blood and the respective CD4+ and CD8+ subsets of αβ T cells. See legend to Fig. 1 for details, abbreviations and statistical testingBack to article page